180 related articles for article (PubMed ID: 14515713)
1. [Graft vs. host disease and graft vs. leukemia/tumor effect].
Okamoto S
Nihon Rinsho; 2003 Sep; 61(9):1484-7. PubMed ID: 14515713
[No Abstract] [Full Text] [Related]
2. [Allorecognition of the recipient after hematopoietic transplantation].
Tiberghien P; Robinet E; Ferrand C; Saas P; Hervé P
Bull Cancer; 2003; 90(8-9):706-10. PubMed ID: 14609760
[TBL] [Abstract][Full Text] [Related]
3. [Hematopoietic stem cell transplantation].
Morishima Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():690-4. PubMed ID: 15861730
[No Abstract] [Full Text] [Related]
4. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
Wu BY; Guo KY; Song CY; Yang ; Li D
Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
[TBL] [Abstract][Full Text] [Related]
5. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
6. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
7. Immunology. A perfect mismatch.
Kärre K
Science; 2002 Mar; 295(5562):2029-31. PubMed ID: 11896262
[No Abstract] [Full Text] [Related]
8. [GVHD and GVL].
Teshima T
Rinsho Ketsueki; 2009 Oct; 50(10):1407-19. PubMed ID: 19915349
[No Abstract] [Full Text] [Related]
9. GVHD pathophysiology: is acute different from chronic?
Toubai T; Sun Y; Reddy P
Best Pract Res Clin Haematol; 2008 Jun; 21(2):101-17. PubMed ID: 18503979
[TBL] [Abstract][Full Text] [Related]
10. [Target antigens for graft-versus-host disease (GVHD) and graft-versus-leukemia/tumor (GVL/T)].
Tanaka J
Nihon Rinsho; 2003 Sep; 61(9):1512-9. PubMed ID: 14515717
[TBL] [Abstract][Full Text] [Related]
11. Minor antigen solves major problem.
Dazzi F; Simpson E; Goldman JM
Nat Med; 2001 Jul; 7(7):769-70. PubMed ID: 11433332
[No Abstract] [Full Text] [Related]
12. [Graft versus host disease and cytokines].
Itoh T
Nihon Rinsho; 2003 Sep; 61(9):1504-11. PubMed ID: 14515716
[TBL] [Abstract][Full Text] [Related]
13. Immunity and transplantation.
Navarrete CV
Vox Sang; 2004 Jul; 87 Suppl1():39-42. PubMed ID: 15200602
[No Abstract] [Full Text] [Related]
14. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Ruggeri L; Capanni M; Urbani E; Perruccio K; Shlomchik WD; Tosti A; Posati S; Rogaia D; Frassoni F; Aversa F; Martelli MF; Velardi A
Science; 2002 Mar; 295(5562):2097-100. PubMed ID: 11896281
[TBL] [Abstract][Full Text] [Related]
16. Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia.
Parmar S; Fernandez-Vina M; de Lima M
Curr Opin Hematol; 2011 Mar; 18(2):98-104. PubMed ID: 21245756
[TBL] [Abstract][Full Text] [Related]
17. Single-cell cloning of human, donor-derived antileukemia T-cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction.
Montagna D; Daudt L; Locatelli F; Montini E; Turin I; Lisini D; Giorgiani G; Bernardo ME; Maccario R
Cancer Res; 2006 Jul; 66(14):7310-6. PubMed ID: 16849581
[TBL] [Abstract][Full Text] [Related]
18. [Role of NK cell receptor-expressing cells in the regulation of GVHD and GVL].
Tanaka J
Rinsho Ketsueki; 2008 Aug; 49(8):598-606. PubMed ID: 18800608
[No Abstract] [Full Text] [Related]
19. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft.
Laurin D; Hannani D; Pernollet M; Moine A; Plumas J; Bensa JC; Cahn JY; Garban F
Transfusion; 2010 Feb; 50(2):418-28. PubMed ID: 19843288
[TBL] [Abstract][Full Text] [Related]
20. Natural killer receptors and graft-vs.-host/ graft-vs.-leukaemia reactions.
Jones DC; Young NT
Vox Sang; 2004 Jul; 87 Suppl 2():15-7. PubMed ID: 15209869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
